Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of AG-1749 in patients on chronic NSAID therapy
jRCT2080220831Phase 3
- Sponsor
- Takeda
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lansoprazole in Peptic ulcer disease (PUD) and NSAID-induced ulcer, sponsored by Takeda.
02
Drugs
lansoprazole
03
Conditions
Peptic ulcer disease (PUD)NSAID-induced ulcer
Beyond the preview
Go deeper on jRCT2080220831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220831.